| Dr Kelly Ann Lorenz, MD | |
|
4315 Diplomacy Dr, Ophthalmology Dept., Anchorage, AK 99508-5926 | |
| (907) 729-1455 | |
| Not Available |
| Full Name | Dr Kelly Ann Lorenz |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 19 Years |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508068636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301086130 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmic Associates A Professional Corporation | 4183515596 | 8 |
News Archive
CardioDx, a cardiovascular genomic diagnostics company, announced today that the company has successfully completed its multicenter validation study for Corus CAD, the first and only gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in patients with stable chest pain.
Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, today announced the publication of data demonstrating that microRNA-206 (miR-206) plays a crucial role in the progression of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and in neuromuscular synaptic regeneration in mice.
CVS Caremark Corporation today announced that its board of directors has approved a new share repurchase program for up to $4.0 billion of the company's outstanding common stock.
› Verified 9 days ago
| Entity Name | Ophthalmic Associates A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255325692 PECOS PAC ID: 4183515596 Enrollment ID: O20040324000384 |
News Archive
CardioDx, a cardiovascular genomic diagnostics company, announced today that the company has successfully completed its multicenter validation study for Corus CAD, the first and only gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in patients with stable chest pain.
Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, today announced the publication of data demonstrating that microRNA-206 (miR-206) plays a crucial role in the progression of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and in neuromuscular synaptic regeneration in mice.
CVS Caremark Corporation today announced that its board of directors has approved a new share repurchase program for up to $4.0 billion of the company's outstanding common stock.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelly Ann Lorenz, MD 12122 Ginami St, Anchorage, AK 99516-2551 Ph: (907) 222-7828 | Dr Kelly Ann Lorenz, MD 4315 Diplomacy Dr, Ophthalmology Dept., Anchorage, AK 99508-5926 Ph: (907) 729-1455 |
News Archive
CardioDx, a cardiovascular genomic diagnostics company, announced today that the company has successfully completed its multicenter validation study for Corus CAD, the first and only gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in patients with stable chest pain.
Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, today announced the publication of data demonstrating that microRNA-206 (miR-206) plays a crucial role in the progression of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and in neuromuscular synaptic regeneration in mice.
CVS Caremark Corporation today announced that its board of directors has approved a new share repurchase program for up to $4.0 billion of the company's outstanding common stock.
› Verified 9 days ago
James Patrick Ford, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1400 | |
David Zumbro, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3500 Latouche St, Suite 250, Anchorage, AK 99508 Phone: 907-561-1530 | |
Dr. Richard Kevin Winkle, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3500 Latouche St Ste 280, Anchorage, AK 99508 Phone: 907-561-1917 | |
Julia D Shatten, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 542 W 2nd Ave, Anchorage, AK 99501 Phone: 907-276-1617 | |
Dr. James Richard Townley Iii, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-1162 | |
Elaine Rose Mcelhinny, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3801 University Lake Dr Fl 2, Anchorage, AK 99508 Phone: 646-506-3297 | |
Carl Eli Rosen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 542 W 2nd Ave, Anchorage, AK 99501 Phone: 907-276-1617 Fax: 907-264-2687 |